Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Merck
Cantor Fitzgerald
Mallinckrodt
Daiichi Sankyo
Teva

Generated: August 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for BGJ398

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patents for BGJ398

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
BGJ398   Try a Free Trial Methods for treating cancer by inhibiting FGFR3/TACC3 fusion protein Astellas Pharma Inc. (Tokyo, JP)   Try a Free Trial
BGJ398   Try a Free Trial Therapeutic agent for FGFR inhibitor-resistant cancer Taiho Pharmaceutical Co., Ltd. (Tokyo, JP)   Try a Free Trial
BGJ398   Try a Free Trial Combinations of LSD1 inhibitors for use in the treatment of solid tumors Oryzon Genomics, S.A. (Madrid, ES)   Try a Free Trial
BGJ398   Try a Free Trial Method of treating cancer using anti-c-Met antibody and FGFR inhibitor combination therapy SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR)   Try a Free Trial
BGJ398   Try a Free Trial Susceptibility of tumors to tyrosine kinase inhibitors and treatment thereof THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (Phoenix, AZ) QUEENSLAND UNIVERSITY OF TECHNOLOGY (Queensland, AU)   Try a Free Trial
BGJ398   Try a Free Trial Combination comprising anti-fibroblast growth factor receptor 2 (FGFR2) antibody and a tyrosine kinase inhibitor Daiichi Sankyo Company, Limited (Tokyo, JP)   Try a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for BGJ398

Drugname Country Document Number Estimated Expiration Related US Patent
BGJ398 Australia 2013228389 2032-03-08   Try a Free Trial
BGJ398 Brazil 112014021897 2032-03-08   Try a Free Trial
BGJ398 Canada 2865388 2032-03-08   Try a Free Trial
BGJ398 China 104379740 2032-03-08   Try a Free Trial
BGJ398 Eurasian Patent Organization 029140 2032-03-08   Try a Free Trial
BGJ398 Eurasian Patent Organization 201491655 2032-03-08   Try a Free Trial
BGJ398 European Patent Office 2824181 2032-03-08   Try a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Accenture
Deloitte
Covington
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.